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Introduction {#sec1}
============

Maintenance of the hematopoietic system requires continuous cellular replenishment from a rare population of hematopoietic stem cells (HSCs) endowed with self-renewal and multilineage differentiation capacities ([@bib25]). At steady state, in the bone marrow (BM) the majority of HSCs remain quiescent in the G~0~ phase of the cell cycle ([@bib3], [@bib11]). When stress occurs and the number of mature cells is reduced in the blood circulation (e.g., bleeding, infection, or chemical/radiation injury), HSCs rapidly enter the cell cycle to give rise to progenitor cells with robust proliferative potential, allowing replenishment of the hematopoietic system ([@bib28]). However, when HSCs are submitted to frequent proliferative stress situations, self-renewal is severely impeded. Similarly, HSCs accumulate changes with age that include a decrease in the regenerative potential and a preferential differentiation into myeloid cells with a loss of support of B cell lineage. Although aging of HSCs was initially thought to be solely influenced by stem cell-intrinsic mechanisms, several recent data indicate that aging of the niche and the microenvironment contribute to aging-associated phenotypes of HSCs ([@bib9], [@bib31]).

The cyclin-dependent kinase (Cdk) 5 and Abl enzyme substrate 1 (CABLES1), also called Ik3-1, is a Cdk-interacting protein that binds to multiple Cdks including Cdk2 ([@bib35]), Cdk3 ([@bib36]), and Cdk5 ([@bib40]). Probably due to its potential to interaction with Cdk, CABLES1 inhibits proliferation in cell line models by enhancing the inhibitory function of Cdk2 mediated by Wee1 ([@bib35]). It also regulates cell proliferation by stabilizing p21^Cip/waf^ (p21) ([@bib32]). In addition to an impact on proliferation, CABLES1 can induce cell death by regulating stability and proteasomal degradation of several members of the p53 family including p53, p73, and TAp63a ([@bib22], [@bib34]). In addition, CABLES1 links Robo-bound Abl kinase to N-cadherin, regulating β-catenin function and transcription ([@bib29]). Likely due in part to its ability to negatively regulate proliferation and induce apoptosis, loss of CABLES1 is associated with a high frequency in multiple types of cancer in humans, including endometrial cancer ([@bib6]), colorectal cancer ([@bib27]), ovarian cancer ([@bib7]), and non-small cell lung cancer ([@bib15]). In mouse models, loss of *Cables1* results in a high incidence of endometrial adenocarcinoma ([@bib41]). In addition, *Cables1* acts as tumor suppressor, regulating intestinal tumor progression in Apc^Min^ mice ([@bib2]). Despite its well-recognized role in cancer, only a few studies have addressed its function in physiologic settings. Current studies indicate a role of CABLES1 in neural differentiation and neurite outgrowth by interacting with Cdk5 (a non-cell-cycle-associated kinase) and Abl ([@bib40]). Moreover, CABLES1 is required for embryonic neural development in the zebrafish model ([@bib13]). Finally, loss of CABLES1 enhances oogenesis associated with reduced oocyte quality ([@bib21]).

Previous studies reported that loss of *Cables1* results in an increase of BM hematopoietic progenitor cells, suggesting that CABLES1 could be a potent regulator of hematopoiesis ([@bib21]). Here, we broaden our understanding of CABLES1 function(s) in hematopoiesis using a *Cables1*^*−/−*^ mouse model. We first report that CABLES1 is predominantly expressed in the progenitor cell compartment, suggesting that CABLES1 is a stemness marker. We also show that absence of *Cables1* in mice markedly affects progenitor cell proliferation. Under stress conditions, absence of *Cables1* delays hematopoietic recovery, while during aging the HSC number is impaired. Finally, the number of mesenchymal stromal cells is reduced in *Cables1*^*−/−*^ mice. Thus, CABLES1 participates in the control of HSC maintenance during aging and under hematopoietic stress.

Results {#sec2}
=======

CABLES1 Is Expressed in Hematopoietic Stem and Progenitor Cells and in Niche Cells {#sec2.1}
----------------------------------------------------------------------------------

The experimental strategy to analyze CABLES1 function in hematopoiesis is depicted in [Figure 1](#fig1){ref-type="fig"}A. The mRNA expression levels of *Cables1* in cells of the hematopoietic and BM microenvironment lineages were analyzed by qRT-PCR. We isolated different subsets of primitive hematopoietic progenitor cells ([@bib19], [@bib24]) and used the mouse brain as reference, as previously described ([@bib40]). *Cables1* mRNA expression level was substantially higher in LSK (Lin^−^Kit^+^Sca-1^+^) cells and SLAM (CD150^+^CD48^−^ LSK) cells compared with differentiated cells, such as B220^+^, CD4^+^, CD8^+^, and Gr-1^+^ cells ([Figure 1](#fig1){ref-type="fig"}B). We also performed analysis of *Cables1* expression in BM niche cells such as osteoblasts, endothelial cells, and mesenchymal stem cells (MSCs) ([@bib23]). All three sorted cell populations expressed *Cables1* mRNAs ([Figure 1](#fig1){ref-type="fig"}B). Of note, the expression of *Cables1* mRNA was not modified during aging in mice ([Figure S1](#mmc1){ref-type="supplementary-material"}). *CABLES1* was also expressed in human CD34^+^ progenitor cells from cord blood (CB-CD34^+^), mobilized peripheral blood (PB-CD34^+^) and human MSCs, in contrast to mature cell populations ([Figure 1](#fig1){ref-type="fig"}C). These results were confirmed at the protein level ([Figures 1](#fig1){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). In addition, the localization of CABLES1 protein in CB-CD34^+^ cells was mainly nuclear ([Figure 1](#fig1){ref-type="fig"}E). These findings suggest that CABLES1 is expressed in the adult BM.Figure 1CABLES1 Expression in Human and Murine Hematopoietic and Niche Cells(A) Experimental strategy used to probe functions of CABLES1 in hematopoiesis. HSC, hematopoietic stem cells; shRNA, short hairpin RNA; 5-FU, 5-fluorouracil.(B) *Cables1* mRNA expression in mouse cells sorted by fluorescence-activated cell sorting: B cells (B220^+^), T cells (CD4^+^ and CD8^+^), myeloid (Gr-1^+^) cells, Lin^−^ (lineage marker-negative cells, namely CD3^−^B220^−^Ter119^−^Gr-1^−^), LSK (Lin^−^c-Kit^+^Sca-1^+^), c-kit^+^ (Lin^−^c-Kit^+^Sca-1^−^), SLAM (CD150^+^CD48^−^LSK), CMPs (Lin^−^Sca-1^+^c-Kit^+^FcR^−^CD34^+^), GMP (Lin^−^Sca-1^+^c-Kit^+^FcR^+^CD34^+^), MEP (Lin^−^Sca-1^+^c-Kit^+^FcR^−^CD34^−^); and in cellular components of the BM microenvironment: osteoblasts (CD45^−^Ter119^−^CD31^−^Sca-1^−^CD51^+^), endothelial cells (CD45^−^Ter119^−^CD31^+^), and MSCs (CD45^−^Ter119^−^CD31^−^Sca^+^CD51^+^). Data are normalized to HPRT transcript levels and mouse brain is used as reference. Data represent a pool from 10 mice and are the mean ± SEM of triplicates. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.(C) CABLES1 expression in human CD34^+^ cells from cord blood (CB-CD34^+^), mobilized peripheral blood (PB-CD34), and mature blood cells (CD4^+^, CD8^+^, CD14^+^, CD19^+^, CD56^+^). Data are normalized to HPRT transcript levels and CD34^+^ cells are used as reference.(D) Expression level of human CABLES1 in CB-CD34^+^, CD3^+^, CD14^+^, and MSCs by western blot. Two different MSC samples are shown as MSC1 and MSC2. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.(E) Immunolocalization of CABLES1 in CB-CD34^+^ cells. Staining with the anti-CABLES1 antibody of human CD3^+^ cells that do not express significant levels of *CABLES1* mRNA is presented in the lower panel.

Steady-State Hematopoiesis in Young Mice Is Not Affected by Cables1 Deficiency {#sec2.2}
------------------------------------------------------------------------------

To address the impact of loss of *Cables1* in hematopoiesis, we assessed complete blood counts in *Cables1*^*−/−*^ and wild-type (WT) mice. Numbers of white blood cells (WBCs), red blood cells (RBCs) and platelets (PLTs) were within normal ranges in 10- to 12-week-old animals ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C) as well as the percentages of B lymphocytes, T lymphocytes, and neutrophils ([Figure S3](#mmc1){ref-type="supplementary-material"}D). BM and spleen cellularities were also comparable between *Cables1*^*−/−*^ mice and their normal counterparts ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). No significant differences in the number of colony-forming unit cells (CFU-Cs) ([Figure S4](#mmc1){ref-type="supplementary-material"}C) and phenotypically defined progenitor cells including granulomonocytic progenitors (GMPs), common myeloid progenitors (CMPs), common lymphoid progenitors (CLPs), and mega-erythroid progenitors (MEPs) were noted between *Cables1*^*−/−*^ and WT mice ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E). Finally, the numbers of phenotypically defined LT-HSC (CD150^+^CD48^−^KSL) were similar between the two groups ([Figure S4](#mmc1){ref-type="supplementary-material"}F). These data demonstrate that loss of *Cables1* does not have a major impact on steady-state hematopoiesis and suggest that blood production is not affected by *Cables1* deficiency.

Cables1 Is an Intrinsic Cell-Cycle Inhibitor in Mouse Progenitor Cells {#sec2.3}
----------------------------------------------------------------------

As CABLES1 is highly expressed in hematopoietic progenitor cells and is involved in cell-cycle regulation and cell death as shown in previous *in vitro* studies ([@bib15]), we evaluated its impact on apoptosis, the levels of mitochondrial reactive oxygen species (ROS), and cell-cycle status of hematopoietic progenitor cells under steady-state conditions. In 10- to 12-week-old *Cables1*^*−/−*^ mice, the proportions of annexin V^+^ DAPI^−^ LSK and SLAM cells and mitochondrial ROS levels were not altered compared with *Cables1*^+*/*+^ mice ([Figures 2](#fig2){ref-type="fig"}A and 2B). However, as illustrated in [Figure 2](#fig2){ref-type="fig"}C, the fraction of cycling cells (Ki67^+^) among LSK cells was significantly higher in the BM of *Cables1*^*−/−*^ mice compared with WT mice ([Figure 2](#fig2){ref-type="fig"}D). Of note, within the more immature subset of HSCs, namely the SLAM population, the proportion of Ki67^+^ cells was not affected ([Figure 2](#fig2){ref-type="fig"}E). To confirm these results, we performed *in vivo* bromodeoxyuridine (BrdU) incorporation assays. In accordance with the Ki67 assays, a higher number of *Cables1*^*−/−*^ LSK cells were BrdU positive ([Figure 2](#fig2){ref-type="fig"}F), whereas the proportion of BrdU^+^ cells in the SLAM cell population was not altered ([Figure 2](#fig2){ref-type="fig"}G). As CABLES1 is a cell-cycle inhibitor for LSK progenitor cells, we compared its expression between G~0~ and cycling LSK cells. We sorted LSK cells in the G~0~, G~1~, and S/G~2~/M phase using Pyronin Y and Hoechst 33342 staining and tested the relative expression of *Cables1* by qPCR. LSK cells in the G~0~ phase showed the highest expression level of *Cables1* compared with LSK cells in the G~1~ and S/G~2~/M phase ([Figure 2](#fig2){ref-type="fig"}H). In addition, *Cables1* expression sharply decreased upon culture of freshly isolated LSK cells in cytokine-containing medium ([Figure 2](#fig2){ref-type="fig"}I). Similarly, *in vivo* treatment of mice with lipopolysaccharide (LPS), leading to quiescence loss of hematopoietic progenitor cells ([Figure 2](#fig2){ref-type="fig"}J), was associated with a sharp decrease in *Cables1* expression ([Figure 2](#fig2){ref-type="fig"}K). Altogether, these results suggest that *CABLES1* expression negatively regulates the cell-cycle status of hematopoietic progenitor cells.Figure 2CABLES1 Is an Intrinsic Cell-Cycle Inhibitor in HSCs of Young Mice(A) Frequencies of annexin V^+^ cells in BM LSK and SLAM populations.(B) Mitosox staining in BM LSK and SLAM cells of 12-week-old WT and *Cables1*^*−/−*^ mice. Data are mean ± SEM from six mice per group, pooled from two independent experiments.(C) Representative flow-cytometric images of cell-cycle analysis by Ki67/DAPI costaining.(D and E) Frequencies of Ki67^+^ cells in BM LSK and SLAM cells.(F and G) Frequencies of BrdU^+^ cells in LSK and SLAM cells. In (A) to (G), five mice were analyzed for each genotype and data represent mean ± SEM.(H) *Cables1* mRNA expression in LSK cells in the G~0~, G~1~, or S/G~2~/M phase. Data represent a pool of 10 mice and mean ± SEM of three independent experiments.(I) *Cables1*^−/−^ mRNA expression in LSK cells cultured in cytokine-containing medium (mouse stem cell factor, IL3, Flt3L) for 24 h; 0 H represents isolated LSK cells before culture. Data are mean ± SEM of three independent experiments.(J) Frequencies of LSK cells in the G~0~ phase (Ki67^−^/DAPI^−^) 24 h after treatment of mice with LPS (n = 6).(K) *Cables1*^−/−^ mRNA expression in LSK cells from LPS-treated mice.(L) Schematic representation of transplantation: *Cables1*^−/−^ or WT BM donor cells were transplanted into lethally irradiated Ly5.1 mice (n = 5).(M) Frequencies of Ki67^+^ LSK and SLAM cells 3 months after reconstitution (see also [Figures S3](#mmc1){ref-type="supplementary-material"}E--S3H). qPCRs are normalized to expression of HPRT. Data are mean ± SEM; unpaired Student\'s two-tailed t test was performed for statistical analysis. LPS, lipopolysaccharides.

As cells from the hematopoietic microenvironment also express CABLES1, we sought to discover whether the role of CABLES1 in progenitor cell proliferation was intrinsic or extrinsic. Thus, we conducted transplantation assays using donor BM cells from *Cables1*^*−/−*^ or *Cables1*^+*/*+^ (Ly5.2) mice that were transplanted into lethally irradiated recipient mice (Ly5.1) ([Figure 2](#fig2){ref-type="fig"}L). Three months after transplantation, the donor contribution was over 90% for each group ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F--S3H). *Cables1*-null derived LSK and SLAM cells had significantly higher proportions of Ki67-proliferating cells than their WT counterparts ([Figure 2](#fig2){ref-type="fig"}M). This illustrates the intrinsic role of CABLES1 in regulating the proliferative status of hematopoietic progenitor cells.

Cables1^−/−^ HSCs Harbor Higher Reconstitution Fitness {#sec2.4}
------------------------------------------------------

We next evaluated the impact of *Cables1* deficiency in competitive transplantation. BM cells from *Cables1*^*−/−*^ (Ly5.2) or *Cables1*^+/+^ (Ly5.2) mice were mixed 1:1 with age-matched BM competitor cells (Ly5.1) and injected into lethally irradiated recipient mice (Ly5.1) ([Figure 3](#fig3){ref-type="fig"}A). During 5 continuous months after transplantation, recipients were analyzed monthly for the percentage of Ly5.2 donor-derived cells in blood. There was significantly 5%, 10%, 13.4%, 13%, and 13% more *Cables1*^*−/−*^-derived cells in the blood of Ly5.1 recipients at 1, 2, 3, 4, and 5 months post reconstitution, respectively ([Figure 3](#fig3){ref-type="fig"}B). A similar higher reconstitution level was observed when *Cables1*^*−/−*^ LSK cells were transplanted ([Figure 3](#fig3){ref-type="fig"}C). The percentages of Ly5.2 donor-derived B cells ([Figure 3](#fig3){ref-type="fig"}D), T cells ([Figure 3](#fig3){ref-type="fig"}E), and granulocytes ([Figure 3](#fig3){ref-type="fig"}F) were similar between the two groups.Figure 3Cables1^−/−^ HSCs Harbor Higher Reconstitution Fitness(A) Schematic representation of competitive repopulation assays.(B) Contributions of donor cells (CD45.2^+^) in blood of recipient mice after transplantation of unfractionated BM cells.(C) Contributions of donor cells (CD45.2^+^) in blood of recipient mice after transplantation of purified BM LSK cells.(D--F) Frequencies of (D) donor-derived B cells, (E) T cells, and (F) granulocytes.(G) Frequencies of donor-derived CD45.2^+^ LSK and SLAM cells in recipients\' BM 2 months after reconstitution (n = 5 per group).(H and I) Percentages of (H) apoptotic donor-derived LSK and (I) SLAM cells.(J) Numbers of CFSE-labeled *Cables1*^*−/−*^ or WT BM cells, evaluated 16 h after homing to BM and spleen of lethally irradiated recipients (n = 6).(K) CFU-C numbers per femur in the BM 4 h after injection.All values are mean ± SEM; unpaired Student\'s two-tailed t test was performed for statistical analysis.

The frequency of *Cables1*^*−/−*^ BM LSK and SLAM cells tended to be higher than that of *Cables1*^+/+^ LSK and SLAM cells in transplanted animals, but this was not significant ([Figure 3](#fig3){ref-type="fig"}G). To characterize the enhanced competitive properties of *Cables1*^*−/−*^ HSCs, we measured the apoptotic rate of LSK and SLAM cells after transplantation. LSK and SLAM cells from *Cables1*^−/−^ mice had similar apoptotic rates compared with *Cables1*^+/+^ LSK and SLAM cells ([Figures 3](#fig3){ref-type="fig"}H and 3I). We also conducted homing experiments. Carboxyfluorescein succinimidyl ester (CFSE)-marked *Cables1*^*−/−*^ or *Cables1*^+/+^ BM cells were injected into irradiated recipient mice. The numbers of CFSE^+^ *Cables1*^*−/−*^ or *Cables1*^+/+^ cells in the BM, spleen, and blood of recipients were comparable ([Figure 3](#fig3){ref-type="fig"}J). The number of progenitor cells that homed to the BM was similar between *Cables1*^*−/−*^ or *Cables1*^+/+^ genotypes ([Figure 3](#fig3){ref-type="fig"}K). Thus, the enhanced competitive capacity of *Cables1*^*−/−*^ HSC is due to neither increased homing capacity nor decreased apoptosis and could be related to their enhanced cell-cycle entry under transplantation settings.

CABLES1 Slows Cell Proliferation of Human CD34^+^ Cells and Regulates p21 Level {#sec2.5}
-------------------------------------------------------------------------------

To examine whether CABLES1 could regulate the proliferation of human hematopoietic progenitor cells, we transduced CB CD34^+^ cells using lentiviral vectors encoding either GFP alone or human CABLES1 ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Transduced cells were sorted based on GFP expression ([Figure S5](#mmc1){ref-type="supplementary-material"}B) and CABLES1 overexpression was verified by western blotting ([Figure 4](#fig4){ref-type="fig"}A). GFP^+^ cells were seeded in methylcellulose to assess the effect of CABLES1 on proliferation of hematopoietic progenitor cells. CABLES1 overexpression not only reduced the number of colonies but also diminished their size ([Figures 4](#fig4){ref-type="fig"}B and 4C). Thus, CABLES1 could slow the proliferation of hematopoietic progenitor cells.Figure 4CABLES1 Slows Cell Growth of Human CD34^+^ Cells and Regulates p21 Level(A) Lentiviral overexpression of human CABLES1 in CB CD34^+^ cells. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.(B) Forty-eight hours after transduction, GFP^+^ CD34^+^ cells were seeded in semisolid media for CFU-C determination. Data represent the mean ± SEM of three independent experiments.(C) Microscopic picture of colonies formed by control vector transduced CB-CD34^+^ cells (left) and CABLES1-overexpressing CB-CD34^+^ cells (right).(D) CABLES1 expression in *CABLES1* shRNA-transduced CB-CD34^+^ cells compared with cells transduced with control shRNA (shC002) and to non-transduced cells (NT). Data represent the mean ± SEM of three independent experiments.(E) CABLES1 protein level after transduction of CB-CD34^+^ cells with sh417758 compared with shC002.(F) Proliferation of CB-CD34^+^ cells after transduction with sh417758 compared with shC002. Data represent the mean ± SEM of three independent experiments.(G) *CABLES1* mRNA expression in cultured CB-CD34^+^ cells. Values are expressed as mean ± SEM; Student\'s unpaired two-tailed t test was performed for statistical analysis. Experiments were performed twice.(H) Protein levels of CABLES1 and p21 in CB-CD34^+^ cells 24 h after culture.(I) Protein levels of CABLES1 and p21 in CB-CD34^+^ cells overexpressing CABLES1.(J) Protein levels of CABLES1 and p21 in CB-CD34^+^ cells transduced with *CABLES1* shRNAs.(K and L) Mean fluorescence intensity (MFI) of p21 in BM LSK (K) and SLAM (L) cells of 12-week-old WT and *Cables1*^−/−^ mice. Data are mean ± SEM from six mice per group, pooled from two independent experiments.

To further investigate the effect of CABLES1 on cell proliferation, we next silenced *CABLES1* expression in CB-CD34^+^ cells using a short hairpin RNA (shRNA) strategy. A sharp reduction of *CABLES1* mRNA was observed using two different shRNAs ([Figures 4](#fig4){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}C), and decreased protein levels ([Figure 4](#fig4){ref-type="fig"}E) were confirmed in *CABLES1* shRNA-transduced CD34^+^ cells compared with control shRNA-transduced CD34^+^ cells. The proliferation rate of CD34^+^ cells transduced with *CABLES1* shRNA was higher compared with control shRNA-transduced cells ([Figure 4](#fig4){ref-type="fig"}F). CABLES1 has previously been demonstrated to interact with the master regulator CDKI p21, inducing inhibition of cell proliferation and apoptosis ([@bib32]). Thus, we investigated the potential role of p21 in CABLES1 effects on cell proliferation. Similarly to murine progenitor cells, CABLES1 expression decreased upon cytokine stimulation of CD34^+^ cells ([Figure 4](#fig4){ref-type="fig"}G). This decrease was accompanied by a parallel reduction in the level of p21 protein expression ([Figure 4](#fig4){ref-type="fig"}H). Strikingly, an increase in p21 protein expression was found in CB-CD34^+^ cells overexpressing CABLES1 compared with control GFP-expressing cells ([Figure 4](#fig4){ref-type="fig"}I). Furthermore, a reduction in p21 protein level was observed in *CABLES1* shRNA-transduced CD34^+^ cells compared with control shRNA-transduced CD34^+^ cells ([Figure 4](#fig4){ref-type="fig"}J). No change in p21 mRNA expression was noted in *CABLES1* shRNA-transduced CD34^+^ cells compared with control shRNA-transduced CD34^+^ cells (data not shown). To assess whether our *in vitro* results on human cells were representative of the CABLES1-p21 link, we evaluated p21 protein level in murine *Cables1* WT and knockout (KO) LSK and SLAM cells. In accordance with our *in vitro* strategy using shRNA in human cells, our analysis showed that the protein levels of p21 was decreased in *Cables1*^*−/−*^ LSK ([Figure 4](#fig4){ref-type="fig"}K) and LSK SLAM cells ([Figure 4](#fig4){ref-type="fig"}L). Thus, our results suggest a role for CABLES1 in the regulation of p21 protein expression.

Loss of Cables1 Delays Hematopoietic Regeneration after 5-FU Treatment {#sec2.6}
----------------------------------------------------------------------

Recent reports suggest that p21 regulates progenitor cell proliferation during periods of stress. As CABLES1 expression is correlated with p21 protein level, we reasoned that *Cables1*^*−/−*^ mice might be more sensitive to hematopoietic injury, for example the chemotherapy agent 5-fluorouracil (5-FU) or irradiation. Therefore, 3-month-old *Cables1*^*−/−*^ and littermate control mice were treated with a single dose of 5-FU (250 mg/kg body weight). In treated *Cables1*^*−/−*^ mice, WBC ([Figure 5](#fig5){ref-type="fig"}A) recovery was delayed. In addition, 10 days after 5-FU challenge, the BM of *Cables1*^*−/−*^ mice was hypocellular, characterized by a paucity of hematopoietic clusters in both osteoblastic and vascular zones compared with the BM of *Cables1*^+/+^ mice ([Figures 5](#fig5){ref-type="fig"}B and 5C). Hematopoietic clusters were seen in close contact to the bone osteoblastic zone. In line with an impaired hematopoietic recovery, progenitor cell numbers were lower in the BM ([Figure 5](#fig5){ref-type="fig"}D), spleen ([Figure 5](#fig5){ref-type="fig"}E), and blood ([Figure 5](#fig5){ref-type="fig"}F) of *Cables1*^*−/−*^ mice. Similar results were obtained when mice were challenged with cyclophosphamide ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6D) or using moderate doses of ionizing radiation ([Figure S6](#mmc1){ref-type="supplementary-material"}E). Therefore, CABLES1 expression favors hematopoietic recovery in response to hematopoietic stress.Figure 5Loss of *Cables1* Delays Hematopoietic Regeneration after 5-FU TreatmentThree-month-old *Cables1*^*−/−*^ and WT mice were treated with a single dose of 5-FU (250 mg/kg body weight).(A) WBC counts (3--5 mice for each time point).(B) BM cellularity of WT and *Cables1*^*−/−*^ mice 10 days after 5-FU treatment.(C) Microscopic images of BM from WT and *Cables1*^*−/−*^ mice 10 days after 5-FU treatment. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.(D--F) Total numbers of CFU-C in (D) BM, (E) spleen, and (F) blood of 5-FU-treated WT and *Cables1*^*−/−*^ mice.Values are mean ± SEM; Student\'s unpaired two-tailed t test was performed for statistical analysis.

Loss of Cables1 Is Associated with Defective Hematopoiesis over Time {#sec2.7}
--------------------------------------------------------------------

Given the impact of CABLES1 on hematopoietic recovery under hematopoietic stress conditions and the inability of *Cables1*-deficient HSCs to tolerate stress, we expected that CABLES1 might play a prominent role during aging. Interestingly, aged (21-month-old) *Cables1*^*−/−*^ mice displayed a significant increase in WBC counts compared with age-matched controls, while young (3-month-old) or middle-aged (8-month-old) *Cables1*^*−/−*^ mice had WBC numbers similar to those of their counterparts ([Figure 6](#fig6){ref-type="fig"}A). No significant changes in RBC and platelet counts were observed between *Cables1*-deficient mice and their controls during the process of aging (data not shown). It has been documented that the frequencies of B cell precursors within the BM are markedly diminished by 4--5 months of age in mice. However, paradoxically, this is not accompanied by a similar decline in the mature cells at the periphery due to compensatory mechanisms such as increased lifespan of B cells ([@bib20]) ([@bib18]). In line with this, differential analysis of blood cells of *Cables1*^+/+^ animals showed no significant variations in the percentage of circulating B lymphocytes during aging ([Figures 6](#fig6){ref-type="fig"}B, 6C, and [S3](#mmc1){ref-type="supplementary-material"}D). However, we observed a significant decrease in the B cell percentages in 21-month-old *Cables1*^*−/−*^-deficient mice compared with age-matched controls ([Figure 6](#fig6){ref-type="fig"}B). In contrast, the percentage of circulating mature myeloid cells (Gr-1^+^) was significantly increased, making this cell population accountable for the increase in total leukocyte counts. No significant differences in WBC subtypes in middle-aged animals were observed between both genotypes ([Figure 6](#fig6){ref-type="fig"}C). We next wondered whether *Cables1*^−/−^ progenitor cell compartments were likewise perturbed during aging. There were no differences in BM cellularity between WT and *Cables1*^−/−^ mice during aging ([Figure S7](#mmc1){ref-type="supplementary-material"}). However, BM clonogenic progenitor, LSK cell, and SLAM cell numbers were increased in middle-aged *Cables1*^−/−^ mice compared with age-matched controls ([Figures 6](#fig6){ref-type="fig"}D--6F). Strikingly, the number of these progenitors and LSK and LSK SLAM cells was reduced in aged *Cables1*^−/−^ mice compared with age-matched controls ([Figures 6](#fig6){ref-type="fig"}D--6F). Consistent with the results from young animals, LSK cells from middle-aged *Cables1*^−/−^ mice displayed a significantly higher proliferation rate than their WT counterparts ([Figure 6](#fig6){ref-type="fig"}G). Of importance, the frequency of dividing cells (BrdU^+^) within BM SLAM cells was higher in *Cables1*^−/−^ mice compared with WT controls ([Figure 6](#fig6){ref-type="fig"}H).Figure 6Loss of *Cables1* Is Associated with Defective Hematopoiesis in Aged Mice(A) WBC counts in WT and *Cables1*^*−/−*^ mice at different ages.(B--D) WBC subtypes (B220^+^, CD3^+^, Gr-1^+^) in (B) 21-month-old (n = 6) and (C) 8-month-old (n = 5) mice. (D) Total BM CFU-C numbers of 3-, 8-, and 21-month-old *Cables1*^*−/−*^ and WT mice (n = 5--6).(E and F) Total numbers of (E) LSK and (F) SLAM cells in 3-, 8-, and 21-month-old *Cables1*^*−/−*^ and WT mice (n = 5--6). See also [Figure S7](#mmc1){ref-type="supplementary-material"}.(G and H) Frequencies of BrdU^+^ LSK (G) and SLAM cells (H) in 8-month-old mice after 12 days of BrdU exposure (n = 6).(I) Survival of 8-month-old mice treated weakly with 5-FU.(J) Percentages of myeloid-biased HSC (CD41^+^CD150^+^LSK) within the CD150^+^LSK compartment in *Cables1*^*−/−*^ and WT mice (n = 10).(K) Frequency of BM LSK/CD34^+^/CD135^+^ cells in *Cables1*^*−/−*^ and WT mice (n = 10 for 8-month-old mice; n = 5 for 21-month-old mice).(L) Frequency of CLP in BM of *Cables1*^*−/−*^ and WT mice (n = 5).(M and N) CFU-C numbers in blood (M) and spleen (N) of 3-, 8-, and 21-month-old *Cables1*^*−/−*^ and WT mice (n = 6). See also [Figures S5](#mmc1){ref-type="supplementary-material"}D--S5F.Data are expressed as mean ± SEM. Log-rank (Mantel-Cox) test was applied for comparing survival between WT and *Cables1*^*−/−*^ mice. Student\'s unpaired two-tailed t test was performed for the other experiments.

To investigate the consequences of quiescence loss in *Cables1*^−/−^ HSC, we studied the effect of a weekly injection of 5-FU. 5-FU injection induces myeloablation by preferentially eliminating actively cycling cells, which in turn activates quiescent stem cells to restore the ablated hematopoietic system. Thus weekly injection of 5-FU leads to HSC depletion, resulting in death of the mice due to BM failure. Strikingly, *Cables1*^−/−^ mice had an increased sensitivity to serial 5-FU treatment and showed a decreased median survival compared with WT animals ([Figure 6](#fig6){ref-type="fig"}I). Finally, no significant differences in the number of apoptotic annexin V^+^/DAPI^−^ cells within hematopoietic progenitor cells were detectable (data not shown), excluding that differences in apoptosis contributed to the elevated number of HSCs found in the BM of middle-aged *Cables1*^−/−^ mice. Preferential differentiation into myeloid cells with loss of support for the B cell lineage is one of the characteristics of aged hematopoiesis ([@bib8]). Therefore, we asked whether *Cables1*^−/−^ HSCs displayed an aging-like phenotype using the CD41 and CD150 markers as previously described ([@bib12]). Of note, the relative frequency of myeloid-biased HSCs phenotypically defined by positive expression of CD41 in CD150^+^ LSK cell population was higher in aged *Cables1*^−/−^ mice compared with WT mice ([Figure 6](#fig6){ref-type="fig"}J). We also analyzed the frequency of the LSK/CD34^+^/CD135^+^ cell population, which is enriched for the lymphoid-primed multipotent progenitors. No difference was found between the two genotypes ([Figure 6](#fig6){ref-type="fig"}K). Similarly, the numbers of CLPs were comparable between the two genotypes ([Figure 6](#fig6){ref-type="fig"}L). In searching for the source of hematopoietic abnormalities, we assessed CFC frequency in blood and an extramedullary hematopoietic site, the spleen. Notably, both middle-aged and 21-month-old *Cables1*-deficient mice displayed increased CFU-C frequencies in blood ([Figure 6](#fig6){ref-type="fig"}M) and spleen ([Figure 6](#fig6){ref-type="fig"}N) compared with age-matched controls. Since increased mobilization could be explained by an abnormal response to CXCL12 ([@bib10]), the main chemokine involved in retention of progenitor cells within the BM, *in vitro* chemotactic assays in response to CXCL12 were performed. No significant difference was observed between the two genotypes ([Figure S5](#mmc1){ref-type="supplementary-material"}D). In addition, CABLES1 overexpression in U937 and HL-60 cells did not modify their chemotactic response to CXCL12 ([Figures S5](#mmc1){ref-type="supplementary-material"}E and S5F). Overall, our data demonstrate that the loss of *Cables1* is associated with defects in blood counts, HSC activation, and hematopoietic stem and progenitor cell mobilization during aging.

Environmental Defects Are Involved in the Defective Hematopoiesis of *Cables1*^−/−^ Mice {#sec2.8}
----------------------------------------------------------------------------------------

Since our results showed significant CABLES1 expression in BM niche cells, we next investigated the putative role of the BM microenvironment in abnormal hematopoiesis of *Cables1*^−/−^ mice. We thus conducted transplantation assays in which lethally irradiated *Cables1*^−/−^ or littermate control mice were used as recipients for WT CD45.1^+^ transplant BM cells ([Figure 7](#fig7){ref-type="fig"}A). Four months after reconstitution, *Cables1*^−/−^ recipient mice displayed a significant decrease in relative B cell donor counts with a significant increase in the frequency of mature myeloid cells ([Figures 7](#fig7){ref-type="fig"}B and 7C). We also determined whether the increased susceptibility of *Cables1*^−/−^ mice to serial 5-FU injection was cell autonomous or related to an abnormal microenvironment. *Cables1*^−/−^ or WT BM cells were transplanted into lethally irradiated recipients of both genetic backgrounds in order to obtain chimeric mice. Four months after hematopoietic reconstitution, 5-FU was injected three times at 10-day intervals and survival was monitored ([Figure 7](#fig7){ref-type="fig"}D). As expected, most (12/13) *Cables1*^−/−^/*Cables1*^−/−^ mice died after 5-FU treatment while fewer WT/WT mice (4/12) succumbed, recapitulating our observation in middle-aged straight *Cables1*^−/−^ mice. Conversely, *Cables1*^*−/−*^ recipient mice reconstituted with either *Cables1*^+/+^ or *Cables1*^−/−^ BM cells showed a decreased median survival, compared with *Cables1*^+/+^ recipient mice reconstituted with WT or *Cables1*^−/−^ BM cells. Of note, *Cables1*^−/−^ recipient mice reconstituted with either *Cables1*^−/−^ or WT BM cells showed no significant difference in survival curves, and this was also observed for WT recipient groups transplanted with *Cables1*^−/−^ or littermate control BM cells. Overall, these results indicate that the lack of *Cables1* in hematopoietic cells is not sufficient to provide a disadvantage to mice treated with repeated cycles of 5-FU, and suggest that the increased susceptibility of *Cables1*^−/−^ mice to 5-FU is mainly related to an abnormal hematopoietic microenvironment. To substantiate this finding, we quantified the mesenchymal stromal progenitor cells in the BM of *Cables1*^−/−^ and *Cables1*^+/+^ mice by CFU-fibroblast (CFU-F) assays. CFU-F frequencies were comparable in the BM of 3-month-old mice ([Figure 7](#fig7){ref-type="fig"}E). However, middle-aged and aged *Cables1*^−/−^ mice displayed a lower frequency of CFU-F compared with their age-matched counterparts ([Figures 7](#fig7){ref-type="fig"}F and 7G). These data show that the BM microenvironment is altered in *Cables1*^−/−^ during aging. Altogether, our results indicate that CABLES1 plays both intrinsic and extrinsic roles in hematopoiesis, as summarized in [Figure 7](#fig7){ref-type="fig"}H.Figure 7Environmental Defects Are Involved in Abnormal Hematopoiesis of Aged *Cables1*^*−/−*^ Mice(A) Schematic representation of BM transplantation.(B and C) Frequencies of (B) donor-derived B cells (B220^+^) and (C) myeloid cells (Gr-1^+^) 4 months after reconstitution (n = 8).(D) Survival of chimeric mice after weekly treatment with 5-FU. Log-rank (Mantel-Cox) test was applied for comparing survival between the different groups.(E--G) BM CFU-F frequency of (E) 3-, (F) 8-, and (G) 21-month-old WT and *Cables1*^*−/−*^ mice. Data are expressed as means ± SEM. Student\'s unpaired two-tailed t test was performed for statistical analysis.(H) Illustrative diagram depicting the main identified roles for CABLES1.

Discussion {#sec3}
==========

Here, we report that CABLES1 plays at least two important roles in the regulation of the HSC pool. One of these is cell autonomous, mainly evidenced in stress conditions; the second role relates to the microenvironment and underscores the role of CABLES1 during aging of HSCs.

The first preliminary evidence for a role of CABLES1 in the regulation of hematopoiesis came from the observation that the number of progenitor cells was slightly increased in the BM of *Cables1*^−/−^ mice ([@bib21]). Our data revealed that the cell-cycle status of HSCs was not altered in steady-state young animals. In contrast, we revealed an enhanced proliferative status of HSCs when transplanted into WT recipients, suggesting that enhanced proliferation of *Cables1*^−/−^ HSCs may operate preferentially during hematopoietic stress. This could explain the slightly higher competitive characteristics of *Cables1*^−/−^ HSCs over their WT counterparts. *Cables1*^−/−^ HSCs displayed higher reconstitution fitness despite hyperproliferation under transplantation settings. This indicates that hyperproliferation per se does not necessarily inhibit stem cell function. In line with this, the knockout of some genes including cell-cycle regulatory genes such as Cdkn2c or Cdkn2a enables preservation or higher repopulation potential despite increased HSC proliferation ([@bib16], [@bib37], [@bib38]). Thus, our results suggest that CABLES1 controls progenitor proliferation through a cell-autonomous mechanism and that it is required for quiescence of HSCs especially under stress conditions.

Several studies have previously demonstrated that CABLES1 is present in a multimolecular complex containing p21/Cip ([@bib33]). The cyclin-dependent kinase inhibitor p21^Cip1/Waf1^ is a G~1~ checkpoint regulator that selectively regulates HSCs and progenitor cell behavior under stress conditions ([@bib4], [@bib26]). Using overexpression experiments, we showed that enhanced CABLES1 expression in human progenitor cells clearly correlated with an increase in p21 protein expression. Inversely, when an shRNA strategy was used, decreased CABLES1 expression correlated with a decrease in p21 protein expression. Mechanistically, CABLES1 interferes with proteasome subunit alpha type 3 (PMSA3) binding to p21 and protects p21 from proteasomal degradation ([@bib32]). In line with these studies, we showed that p21 mRNA expression is not affected by CABLES1 expression, suggesting that CABLES1 may control p21 levels in hematopoietic cells through a post-transcriptional mechanism.

At steady state in young animals, *Cables1* deletion affected essentially the cell cycle of progenitor cells with only few effects on HSC numbers and cell cycle. Deletion of p21 has also a limited role on steady-state hematopoiesis and its impact on HSCs was only observed under stress conditions, such as 5-FU treatment and irradiation ([@bib5], [@bib26]) similarly to what we observed in *Cables1*^−/−^ mice. Despite these similarities, our experiments revealed that the deletion of *Cables1* does not completely recapitulate the *p21* phenotype. Indeed, under transplantation settings, *Cables1*^−/−^ HSCs displayed a higher proliferative status while the deletion of *p21* led to PMSA3 decreased ([@bib5]) or normal reconstitution ([@bib26]). Thus, although these observations are consistent with the model that inhibition of proliferation by CABLES1 operates at least in part through an increase of p21 activity, other CABLES1 targets could be involved. Indeed, CABLES1 has a cyclin-like domain, which is a key element in its interactions with multiple Cdks including Cdk3, Cdk2, and Cdk5 ([@bib22], [@bib40]). CABLES1 is phosphorylated by Cdk2 or Cdk3 bound to cyclin A and cyclin E ([@bib36]). In addition, CABLES1 enhances Cdk2 tyrosine phosphorylation at residue 15 by Wee1 family kinase, leading to the inhibition of Cdk2 activity and suppression of cell proliferation ([@bib35]). Therefore, regulation of these targets by CABLES1 can account for increased proliferative capacity of *Cables1*-deficient cells under transplantation.

By further investigating *Cables1*^−/−^ mice, we observed that loss of *Cables1* is associated with defective hematopoiesis over time. At 21 months of age, *Cables1*^−/−^ mice displayed a significant increase in myeloid cell numbers in the periphery without significant alterations in B cell counts. This phenotype is not transplantable, suggesting that this feature is not HSC autonomous.

To understand why *Cables1*^−/−^ mice display increased 5-FU sensitivity, we conducted transplantation assays in which lethally irradiated *Cables1*^−/−^ or littermate control mice were used as recipients for WT transplant BM cells. We also generated reverse chimera by transplanting *Cables1*^−/−^ BM cells to irradiated *Cables1*^−/−^ or littermate control mice. Using this strategy, we demonstrated that the increased susceptibility of *Cables1*^−/−^ mice to 5-FU is mainly dependent on the BM microenvironment. Indeed, 5-FU not only acts on HSCs but also on niche cells that become stimulated, thus inducing a stimulating effect on HSCs ([@bib17]). Our hypothesis is supported by our results showing that niche cells, including MSCs, express high levels of *CABLES1* mRNA and protein. In addition, we have afforded evidence that BM from *Cables1*^−/−^ mice have lower numbers of MSCs, indicating that CABLES1 is important for stromal cells. MSCs are the principal cells that mediate retention of progenitor cells within the BM, and their deficiency is often associated with a marked exhaustion of HSCs and increased mobilization of progenitor cells. The phenotype of middle-aged *Cables1*^−/−^ mice strikingly mimicked transgenic mice with such MSC depletion. It remains to be determined how CABLES1 regulates the dynamic adaptation of niche cells to replicative stress and how this adaptation influences the regeneration of HSCs. One potential mechanism could be stress- or age-associated decreases in the adhesion potential of *Cables1*^−/−^ MSCs ([@bib29]). The use of *in vitro* and *in vivo* models as described recently will help to more deeply understand how CABLES1 regulates the dynamic adaptation of niche cells to replicative stress and how this adaptation influences the regeneration of HSCs ([@bib17]).

In conclusion, we report here an important role of CABLES1 in the direct regulation of progenitor cell cycle and long-term hematopoiesis. Our results suggest that the observed defects in *Cables1*^−/−^ mice may be due in part to the potential role of CABLES1 in regulating p21 levels. The present results also underscore the protective role of CABLES1 during genotoxic stress and aging.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Heterozygous *Cables1*^+/−^ C57BL/6 (CD45.2) background mice were previously described and kindly provided by B.R.R. ([@bib41]). All experiments were approved by an appropriate institutional review committee (C2EA-26, Animal Care, Villejuif, France).

Culture of Human Cord Blood CD34^+^ Cells and Mesenchymal Stem Cells {#sec4.2}
--------------------------------------------------------------------

CB samples from normal full-term newborn infants were collected after normal vaginal delivery with informed written consent. CD34^+^ cells separated using a magnetic cell-sorting system (miniMACS; Miltenyi Biotec) were cultured as previously described ([@bib1]). MSCs were obtained by culture of BM from healthy donors in plastic dishes in MSC expansion medium (Miltenyi Biotech). Chemotaxis assays in response to CXCL12 were performed as previously described ([@bib30]).

Flow Cytometry {#sec4.3}
--------------

BM cells were analyzed on FACS CANTO II (Becton Dickinson) and sorted on an Influx flow cytometer (BD). HSC cell-cycle analysis was performed with either Ki67/Hoechst 33342 or BrdU/Hoechst 33342 costaining. Intracellular p21 was assessed with anti-p21 antibody (Thermo Fisher Scientific) followed by a goat anti-rabbit AlexaFluor 488 antibody, according to the supplied protocol of fixation/permeabilization BD Cytofix/Cytoperm. Mitochondrial ROS detection was assessed after staining for 20 min with 10 μM Mitosox at 37°C as previously described ([@bib39]). BM cells stained for surface markers were incubated with AlexaFluor 647-conjugated annexin V (Invitrogen) and DAPI, according to the supplied protocol. To avoid false-positive annexin V staining, we processed cells at 2°C--8°C and analyzed them within 4 h after recovery from mice.

Reconstitution Assays {#sec4.4}
---------------------

To establish chimeric mice, we lethally irradiated 12- to 14-week-old *Cables1*^−/−^ and *Cables1*^+/+^ mice and 24 h later, mice were reconstituted with 5 × 10^6^ *Cables1*^−/−^ or *Cables1*^+/+^ BM cells from 8- to 10-week-old mice. The reconstitution was analyzed by sampling blood once per month. Mice were euthanized 5 months after transplantation for analyzing test cell-derived HSCs and their cycling status by Ki67 assay. Half of the spleen and one femur per mouse were kept for immunohistochemistry.

For competitive assays, cells (3 × 10^6^ BM cells/host) from *Cables1*^−/−^ and *Cables1*^+/+^ donor mice (CD45.2) and an equal number of CD45.1 BM cells (competitor cells) were co-transplanted into lethally irradiated (9.5 Gy) CD45.1 recipients. Blood was collected monthly after transplantation, and the relative contribution of test cells (CD45.2) to competitor cells (CD45.1) in the reconstituted host was quantified by flow cytometry. For reconstitution with purified cells, WT or KO BM LSK cells (8,000 cells per mouse) were injected together with 1.5 × 10^5^ CD45.1 BM cells.

Treatment of Mice with 5-FU or LPS {#sec4.5}
----------------------------------

Mice were injected intraperitoneally with 5-FU (Fluorouracil Dakota Pharm, Paris, France) at 150 mg/kg body weight for survival rates of mice or at 250 mg/kg body weight for hematopoietic regeneration analysis. Mice were treated with 4 mg of cyclophosphamide followed by 5 days of 5 μg of recombinant human (rh) granulocyte-colony stimulating factor per day subcutaneously. *Cables1*^−/−^ and *Cables1*^+/+^ mice were subjected to TBI (6 Gy). Mice were injected with LPS (200 μg/kg body weight) and sacrificed 24 h later.

Transduction of Human CB CD34^+^ Cells {#sec4.6}
--------------------------------------

Human *CABLES1* cDNA sequence was cloned into the lentiviral vector pTrip-MND-IRES-GFP vector (kindly provided by F. Pflumio, CEA, L\'Hay-les-Roses, France). *CABLES1* shRNAs (417758, 433848) and the control shc002, all from Sigma, were cloned into a lentiviral vector (pRRLsin-PGK-eGFP-WPRE, Genethon). Cell transduction was performed as previously described ([@bib14]). To test the effect of CABLES1 overexpression on CD34^+^ cell proliferation, we sorted 4,000 GFP^+^ cells 48 h after transduction and seeded them in human methylcellulose supplemented with rh stem cell factor (50 ng/mL, Biovitrum, Stockholm, Sweden), rh interleukin-3 (100 U/mL, Peprotech, France), and rh erythropoietin (1 U/mL, Amersham). Colonies were counted after 2 weeks.

Data Processing and Statistical Analysis {#sec4.7}
----------------------------------------

Flow-cytometry results were analyzed by BD FACS Diva software. Results were evaluated using Student\'s unpaired t test by GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). Results are presented as means ± SEM and the value of p \< 0.05 was determined as significant, with p \< 0.01 and p \< 0.001 highly significant.
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